We invite you to engage in an interactive nintely minute roundtable led by EverythingALS consortia of Pharma partners, sensor companies, neurologists, data scientists, regulators and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.
Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in EverythingALS research, which will be expanded to include analyzing data from wearables and smartphones.
As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below.
This is an invite only event.
Hosts & Speakers
Friday Sept 15, 2023
10:30AM - Noon ET I 07:30 - 09:00AM PT
Welcome and Consortia Updates
Indu Navar - CEO and Founder, EverythingALS
Keynote : Family living with ALS
Sean and Dina Cellini Clancy will share with us the impact of ALS on family, and support and shared-decisions making
Research Learnings & Insights
Speech Language Pathologist (SLP) study - Dr. Lyle Ostrow
Muti-modal Radcliff study walk through - Steve Kowalski & Stephanie Henze
Asymptomatic Carrier study - Indu Navar
Summit recap and next steps
Key takeaways from the July 24th Onsite Digital Biomarker summit
By Josh Cosman, Bryan Hansen, Linus Sun & Christian Rubio
Discussion and Q&A
Looking Ahead and closing remarks - Indu Navar